PE20070590A1 - PROCESO PARA LA SINTESIS DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS COMO INHIBIDORES DE SELECTINA - Google Patents

PROCESO PARA LA SINTESIS DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS COMO INHIBIDORES DE SELECTINA

Info

Publication number
PE20070590A1
PE20070590A1 PE2006001208A PE2006001208A PE20070590A1 PE 20070590 A1 PE20070590 A1 PE 20070590A1 PE 2006001208 A PE2006001208 A PE 2006001208A PE 2006001208 A PE2006001208 A PE 2006001208A PE 20070590 A1 PE20070590 A1 PE 20070590A1
Authority
PE
Peru
Prior art keywords
tetrahidrobenzo
quinolin
hydroxy
synthesis
compounds substituted
Prior art date
Application number
PE2006001208A
Other languages
English (en)
Inventor
Youchu Wang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20070590A1 publication Critical patent/PE20070590A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A PROCESOS DE PREPARACION DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS DE FORMULA (VI) EN DONDE R1 ES INDEPENDIENTEMENTE H, HALOGENO, OH, CN, ENTRE OTROS; R2 ES H, HALOGENO, OH, CN, ALQUILO(C1-C6) ENTRE OTROS; R3 INDEPENDIENTEMENTE H, HALOGENO, ENTRE OTROS; p Y q SON INDEPENDIENTEMENTE 1, 2 O 3. TAL COMO ACIDO 2-(4-CLOROBENCIL)-3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO, QUE CONSISTE EN HIDROLIZAR EN UN MEDIO ACIDO UN COMPUESTO (III), Y LUEGO ACOPLAR EN UN MEDIO QUE COMPRENDE ALCOHOL Y UNA BASE, EL PRODUCTO OBTENIDO CON UN COMPUESTO (V) OBTENIENDOSE DE ESTA FORMA EL COMPUESTO VI. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON INHIBIDORES DE SELECTINA Y SON UTILES PARA EL TRATAMIENTO DE PROCESOS DE INFLAMACION Y ADHESION O ATEROSCLEROSIS
PE2006001208A 2005-10-05 2006-10-04 PROCESO PARA LA SINTESIS DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS COMO INHIBIDORES DE SELECTINA PE20070590A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72373405P 2005-10-05 2005-10-05

Publications (1)

Publication Number Publication Date
PE20070590A1 true PE20070590A1 (es) 2007-07-11

Family

ID=37672216

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001208A PE20070590A1 (es) 2005-10-05 2006-10-04 PROCESO PARA LA SINTESIS DE COMPUESTOS 3-HIDROXI-7,8,9,10-TETRAHIDROBENZO[h]QUINOLIN-4-CARBOXILICO SUSTITUIDOS COMO INHIBIDORES DE SELECTINA

Country Status (19)

Country Link
US (1) US20070082923A1 (es)
EP (1) EP1931638A1 (es)
JP (1) JP2009511488A (es)
KR (1) KR20080053389A (es)
CN (1) CN101277936A (es)
AR (1) AR058079A1 (es)
AU (1) AU2006302375A1 (es)
BR (1) BRPI0616906A2 (es)
CA (1) CA2624552A1 (es)
CR (1) CR9854A (es)
EC (1) ECSP088340A (es)
GT (1) GT200600447A (es)
IL (1) IL190435A0 (es)
NO (1) NO20081548L (es)
PE (1) PE20070590A1 (es)
RU (1) RU2008112191A (es)
TW (1) TW200738639A (es)
WO (1) WO2007044475A1 (es)
ZA (1) ZA200802990B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090127183A (ko) * 2007-03-30 2009-12-09 와이어쓰 퀴놀린 유도체, 및 이를 포함하는 셀렉틴 억제용 제약 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239280B1 (en) * 1999-06-30 2001-05-29 Merck & Co., Inc. Process for synthesizing biaryl inhibitors of farnesyl-protein transferase
PA8616901A1 (es) * 2003-11-10 2005-05-24 Wyeth Corp Metodos y composiciones para la inhibicion de selectina

Also Published As

Publication number Publication date
TW200738639A (en) 2007-10-16
ZA200802990B (en) 2008-12-31
BRPI0616906A2 (pt) 2011-07-05
AR058079A1 (es) 2008-01-23
NO20081548L (no) 2008-04-28
CA2624552A1 (en) 2007-04-19
WO2007044475A1 (en) 2007-04-19
ECSP088340A (es) 2008-06-30
CR9854A (es) 2008-05-21
CN101277936A (zh) 2008-10-01
AU2006302375A1 (en) 2007-04-19
JP2009511488A (ja) 2009-03-19
IL190435A0 (en) 2008-11-03
EP1931638A1 (en) 2008-06-18
GT200600447A (es) 2007-05-08
US20070082923A1 (en) 2007-04-12
KR20080053389A (ko) 2008-06-12
RU2008112191A (ru) 2009-11-10

Similar Documents

Publication Publication Date Title
AR055779A1 (es) Proceso de preparacion de azoxistrobina y composicion que contiene al compuesto
PE20091834A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona tiofenilo-sustituida como inhibidores de bace-1 y composiciones que los contienen
HK1133257A1 (es)
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
PE20070367A1 (es) Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa
TW200716511A (en) New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
CR10095A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
MY140841A (en) Indozolone derivatives as 11b-hsd1 inhibitors
PE20071061A1 (es) Derivados de carbonilo como inhibidores de peptidil-deformilasa (pdf)
JO2926B1 (en) Organic compounds
PE20061142A1 (es) Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen
PE20141534A1 (es) Derivados de imidazol como inhibidores de la enzima pde10a
EA201170053A1 (ru) Способ получения и сушки твердого разагилина в форме основания
BRPI0612475B8 (pt) métodos para a preparação de um composto
WO2007083090A3 (en) Process for the preparation of uracil derivatives
MX2010003849A (es) Antagonistas de cgrp.
PT2049480E (pt) Derivados de 2-arilindole como inibidores da mpges-i
MX2012003615A (es) Composiciones de limpieza abrasivas, acidas, viscosas.
ECSP088525A (es) Proceso para la preparación de aminas
TW200635905A (en) Processes for producing 4-aminoquinazolines
WO2007074475A3 (en) Novel polymorphic forms of ibandronate
EP1512738A4 (en) PROCESS RELATING TO THE PRODUCTION OF FATTY ACID ALKYL ESTER COMPOSITION
ATE447567T1 (de) Verfahren zur herstellung von tryptase- inhibitoren
WO2009140101A3 (en) Imidazopyridine compounds useful as mmp-13 inhibitors
CO5700712A2 (es) Prevencion y tratamiento de la enfermedad de alzheimer

Legal Events

Date Code Title Description
FA Abandonment or withdrawal